Sustained-release lithium carbonate in double-blind study: serum lithium levels, side effects, and placebo response.
The utility and side effects of sustained-release lithium carbonate (Priadel) in a once-per-day dose regimen was investigated with 66 male delinquents, ages 17-24 years, in a double-blind study comparing the antiaggressive effect of lithium carbonate with placebo. Serum lithium levels and symptoms were determined weekly for up to eight drug-free and 12 on-medication weeks. Average daily doses of 1500-1700 mg Priadel gave 24-hour serum lithium levels in the range 0.7-0.9 mEq/liter. Principal side effects were polyuria and shakiness, with other important side effects bring hand tremor, dryness of mouth, nausea, and weakness. No lithium toxicity was observed, and diarrhea was reported infrequently. Placebo response data are presented.
D000293:Adolescent; D000328:Adult; D003692:Delayed-Action Preparations; D006801:Humans; D008094:Lithium / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D008297:Male; D010919:Placebos
D003692:Delayed-Action Preparations; D010919:Placebos; D008094:Lithium